Chiltern Boosts Investment in Endpoint Clinical

Chiltern International Ltd. will make an additional financial investment in Endpoint Clinical, Inc., as part of an effort to further strengthen their strategic partnership, which was established in April 2009.

Glenn Kerkhof, Chiltern’s chief executive officer, said, “Chiltern’s decision to increase our investment in endpoint reflects our aligned vision for the future of endpoint’s PULSE platform, enabling endpoint to provide an unparalleled combination of premium client service and advanced technology solutions. Jon Dole and Tom O’Connell of endpoint have brought a new level of energy and innovation to Interactive Response Technology (IRT). Since our partnership began over a year ago, endpoint has delivered high quality, cost effective services to clients with both accuracy and speed. Endpoint is successfully responding with best- in-class IVR/IWR solutions and as a result exceeding client expectations.”

Jonathan Dole, Endpoint’s chief executive officer, said, “Chiltern has been an excellent partner for us over the past year, and we couldn’t be more pleased with their continued support in our vision for IRT. Chiltern’s global footprint and their overall support of our growing business have proven invaluable in moving us forward. Chiltern’s enthusiasm and investment affirms our confidence in the solutions we are bringing to the marketplace. With PULSE we are delighting our clients with our fresh and logical approach to systems development, giving our customers the agility they need in a constantly changing R&D environment.”